Julie Tepper | Investor Relations |
Brett Monia | Founder, CEO & Director |
Richard Geary | EVP & Chief Development Officer |
Elizabeth Hougen | EVP, Finance & CFO |
Eric Swayze | EVP, Research |
Eugene Schneider | EVP & Chief Clinical Development Officer |
Onaiza Cadoret | EVP, Chief Global Product Strategy & Operations Officer |
Gary Nachman | BMO Capital Markets |
Yanan Zhu | Wells Fargo |
Myles Minter | William Blair & Company |
Yale Jen | Laidlaw & Company |
Brendan Smith | Cowen |
Joseph Stringer | Needham & Company |
Gena Wang | Barclays Bank |
Jessica Fye | JPMorgan Chase & Co. |
Good morning, and welcome to the Ionis Pharmaceuticals Third Quarter 2022 Financial Results Conference Call.
As a reminder, this call is being recorded. And at this time, I would like to turn the conference over to Ms. Julie Tepper, Investor Relations, to lead off the call. Please go ahead, ma'am.